Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;132(4):224-232.
doi: 10.1002/cncy.22778. Epub 2023 Dec 8.

Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation

Kartik Viswanathan  1   2 , D Blake Behrman  1 , Daniel J Lubin  1   2
Affiliations
Free article

Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation

Kartik Viswanathan et al. Cancer Cytopathol. 2024 Apr.
Free article

Abstract

Background: Medullary thyroid carcinoma (MTC) is a rare cancer of parafollicular C-cell origin. The International MTC Grading System (IMTCGS) incorporates mitotic activity, the presence of necrosis, and the Ki67 proliferation rate (PR) to classify MTCs as low or high grade. The ability to predict IMTCGS grade in cytology was assessed.

Methods: MTCs with cytology and subsequent surgical follow-up were reviewed. Cytology slides were reviewed for mitotic figures, apoptoses, and necrosis, and a Ki67 PR was calculated when possible. Findings were correlated with final IMTCGS grade.

Results: Twenty-five MTC fine-needle aspirations (FNAs) were identified, with nine identified as high grade (36%). By using a PR cutoff of 5%, Ki67 on FNA material (Ki67FNA) showed 92% concordance (n = 22 of 24) with surgical Ki67 and a correlation coefficient (R2) of 0.72. Sensitivity and specificity of Ki67FNA for predicting high-grade MTC were 38% and 100%, respectively. Multiple mitotic figures were present in a single slide of 43% (n = 3 of 7) of evaluable high-grade MTCs, whereas only one of 16 low-grade MTCs showed a single mitotic figure. Definitive apoptoses were present in five of seven high-grade MTC FNAs but were absent in 16 low-grade MTCs. The sensitivity and specificity of apoptoses/necrosis on cytology for high-grade MTCs were 71% and 88%, respectively.

Conclusions: Ki67FNA ≥5% shows low sensitivity but high specificity for predicting high-grade MTC. The presence of multiple mitotic figures in a single slide or definitive apoptotic bodies are both highly suggestive of high-grade MTC, and should warrant a close examination for necrosis and a careful Ki67 PR count.

Keywords: International Medullary Thyroid Carcinoma Grading System; Ki67; apoptotic bodies; fine‐needle aspiration; grading; medullary thyroid carcinoma; mitoses; mitotic figures; necrosis; thyroid cytopathology.

PubMed Disclaimer

References

REFERENCES

    1. Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol. 1998;48(3):265‐273. doi:10.1046/j.1365‐2265.1998.00392.x
    1. Shao Y, Li G, Wei T, et al. Distant metastasis in medullary thyroid carcinoma: clinical outcomes and implications of T stage. Clin Endocrinol. 2022;97(5):676‐684.
    1. Sahli ZT, Canner JK, Zeiger MA, Mathur A. Association between age and disease specific mortality in medullary thyroid cancer. Am J Surg. 2021;221(2):478‐484. doi:10.1016/j.amjsurg.2020.09.025
    1. Meng K, Luo H, Chen H, Guo H, Xia W. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: a population‐based study using the SEER 18 database. Medicine. 2019;98(1):e13884. doi:10.1097/md.0000000000013884
    1. Ríos A, Rodríguez JM, Acosta JM, et al. Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma. Ann Surg Oncol. 2010;17(9):2444‐2451. doi:10.1245/s10434‐010‐1021‐4

Supplementary concepts